These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 578651)

  • 41. Immediate decrease by hydrocortisone of the plasma half-life of antipyrine.
    Breckenridge A; Burke CW; Davies DS; Orme ML
    Br J Pharmacol; 1973 Feb; 47(2):434-6. PubMed ID: 4722054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of albumin and alpha-1 acid glycoprotein on elimination of prazosin and antipyrine in the isolated perfused rat liver.
    Oie S; Fiori F
    J Pharmacol Exp Ther; 1985 Sep; 234(3):636-40. PubMed ID: 4032284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distribution of antipyrine in the rat liver.
    Hussein Z; Rowland M
    J Pharm Pharmacol; 1992 Sep; 44(9):766-8. PubMed ID: 1360531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of nifedipine, nitrendipine and verapamil at low concentration on antipyrine metabolism examined by extracorporeal rat liver perfusion.
    Szelag A; Magdalan J; Rutkowska M; Dziewiszek W; Trocha M; Rzepka M; Pieśniewska M; Fereniec L
    Pol J Pharmacol; 2003; 55(2):203-8. PubMed ID: 12926547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of urea on hexobarbital and antipyrine disposition in rats.
    Valentovic M; Bachmann K
    Pharmacology; 1980; 21(3):167-74. PubMed ID: 7413718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of clearance concepts to some literature data on drug metabolism in the isolated perfused liver preparation and in vivo.
    Rowland M
    Eur J Pharmacol; 1972 Mar; 17(3):352-6. PubMed ID: 5022150
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of moderate fluosol-DA hemodilution on gender specific metabolism of antipyrine.
    Shrewsbury RP; White LG
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):455-62. PubMed ID: 2781142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of short-term water deprivation on antipyrine disposition.
    Prasad P; Jung D; Niazi S
    J Pharm Sci; 1985 Mar; 74(3):338-9. PubMed ID: 4009446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic metabolic ability during anaesthesia. Evaluation of antipyrine half-lives and their relation to enflurane metabolism.
    Oikkonen M; Rosenberg PH; Neuvonen PJ
    Anaesthesia; 1984 Jul; 39(7):660-5. PubMed ID: 6465491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of whole-body irradiation on the half-life of antipyrine and on the microsomal enzyme system of rats. Correlation between in vivo and in vitro results.
    Thiriot C; Gaboriaud F; Bernard P
    Enzyme; 1983; 30(3):205-8. PubMed ID: 6354704
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.
    Forrest JA; Finlayson ND; Adjepon-Yamoah KK; Prescott LF
    Br Med J; 1977 May; 1(6073):1384-7. PubMed ID: 861646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enflurane anesthesia and antipyrine metabolism.
    Duvaldestin P; Mauge F; Desmonts JM
    Clin Pharmacol Ther; 1981 Jan; 29(1):61-4. PubMed ID: 7460476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Normal antipyrine metabolism in patients with cholesterol cholelithiasis. Evidence that the disease is not due to generalized hepatic microsomal dysfunction.
    Hepner GW; Vesell ES
    Am J Dig Dis; 1975 Jan; 20(1):9-12. PubMed ID: 1115054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The antipyrine breath test in the rat: a pharmacokinetic model.
    Lockwood GF; Chenery RJ; Oldham HG; Standring P; Norman SJ
    Eur J Drug Metab Pharmacokinet; 1988; 13(3):207-14. PubMed ID: 3149242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impairment of hepatic drug metabolism in alcoholics.
    Harman AW; Frewin DB; Priestly BG; Alexander CB
    Br J Clin Pharmacol; 1979 Jan; 7(1):45-8. PubMed ID: 760741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sex difference in antipyrine 3-hydroxylation. An in vivo-in vitro correlation of antipyrine metabolism in two rat strains.
    Buters JT; Reichen J
    Biochem Pharmacol; 1990 Aug; 40(4):771-7. PubMed ID: 2386545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon reduces hepatic drug metabolism in vivo in mice.
    Taylor G; Marafino BJ; Moore JA; Gurley V; Blaschke TF
    Drug Metab Dispos; 1985; 13(4):459-63. PubMed ID: 2863111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
    Espiritu-Quiza MF; Skinner MH; Blaschke TF
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone.
    Kellermann G; Luyten-Kellermann M; Horning M; Stafford M
    Drug Metab Dispos; 1975; 3(1):47-50. PubMed ID: 234834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.